Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohu Fan

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
European Journal of Clinical Pharmacology|February 1, 2011
Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern ChinaYong Song, Wujun Xue, Puxun Tian, et al.
Human Gene Therapy|February 19, 2010
Induction of human blood group a antigen expression on mouse cells, using lentiviral gene transductionXiaohu Fan, Haili Lang, Xianpei Zhou, et al.
Plos One|February 26, 2013
Combined strategy of endothelial cells coating, Sertoli cells coculture and infusion improves vascularization and rejection protection of islet graftYang Li, Wujun Xue, Hongbao Liu, et al.
BMC Biotechnology|August 27, 2025
A novel feeder cell based on 4-1BBL and membrane-bound IL-21/IL-15 induce highly expansion and anti-tumor effect of natural killer cellsSha Gong, Nan Mei, Jun Wang, et al.
Stem Cells (Dayton, Ohio)|April 5, 2013
Uterine vasculature remodeling in human pregnancy involves functional macrochimerism by endothelial colony forming cells of fetal originPeter I Sipos, Willem Rens, Hélène Schlecht, et al.
Transplantation|April 28, 2016
Antibody-Mediated Rejection in a Blood Group A-Transgenic Mouse Model of ABO-Incompatible Heart TransplantationBruce Motyka, Nella Fisicaro, Szu-I Wang, et al.
Frontiers of Medicine|October 2, 2019
Management of cytokine release syndrome related to CAR-T cell therapyHongli Chen, Fangxia Wang, Pengyu Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)Jian-Qing Mi, Wanhong Zhao, Hongmei Jing, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
European Journal of Clinical Pharmacology|February 1, 2011
Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern ChinaYong Song, Wujun Xue, Puxun Tian, et al.
Human Gene Therapy|February 19, 2010
Induction of human blood group a antigen expression on mouse cells, using lentiviral gene transductionXiaohu Fan, Haili Lang, Xianpei Zhou, et al.
Plos One|February 26, 2013
Combined strategy of endothelial cells coating, Sertoli cells coculture and infusion improves vascularization and rejection protection of islet graftYang Li, Wujun Xue, Hongbao Liu, et al.
BMC Biotechnology|August 27, 2025
A novel feeder cell based on 4-1BBL and membrane-bound IL-21/IL-15 induce highly expansion and anti-tumor effect of natural killer cellsSha Gong, Nan Mei, Jun Wang, et al.
Stem Cells (Dayton, Ohio)|April 5, 2013
Uterine vasculature remodeling in human pregnancy involves functional macrochimerism by endothelial colony forming cells of fetal originPeter I Sipos, Willem Rens, Hélène Schlecht, et al.
Transplantation|April 28, 2016
Antibody-Mediated Rejection in a Blood Group A-Transgenic Mouse Model of ABO-Incompatible Heart TransplantationBruce Motyka, Nella Fisicaro, Szu-I Wang, et al.
Frontiers of Medicine|October 2, 2019
Management of cytokine release syndrome related to CAR-T cell therapyHongli Chen, Fangxia Wang, Pengyu Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1)Jian-Qing Mi, Wanhong Zhao, Hongmei Jing, et al.
Pageof 4